Latest Management of cancer Stories
Co-development agreement, brokered by MaRS Innovation, to advance ultrasound chemotherapy monitoring technology as clinical tool TORONTO, March 12, 2015 /PRNewswire/ -
Conventional cancer treatment with surgery, radiation, and chemotherapy aims to destroy cancer cells. In his new book The Cancer Solution: Taking Charge of Your Life with Cancer, Dr.
MELBOURNE, Australia, March 11, 2015 /PRNewswire/ -- Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"), an emerging healthcare company focusing on the development of
WASHINGTON, March 10, 2015 /PRNewswire-USNewswire/ -- More than 250 researchers, clinicians, physicists and other experts will gather the National Proton Conference (
SAN DIEGO, March 9, 2015 /PRNewswire/ -- Epic Sciences and The Prostate Cancer Clinical Trials Consortium (PCCTC), the leading consortium for Phase 1/2 and Phase 2 clinical trials in prostate
HOUSTON, TX and VANCOUVER, March 5, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has appointed Mr.
Researchers at Northwestern University have announced a cancer-treatment breakthrough based on three decades of work.
New Therapy Will Harness the Power of Patients' Own Immune Systems to Fight Lung Cancer WASHINGTON, March 5, 2015 /PRNewswire-USNewswire/ -- LUNGevity Foundation, the nation's leading lung
CALGARY, March 5, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
Researchers at MIT have developed a new device which uses nanoparticles to block the genes that confers drug resistance, offering a new way to prevent chemotherapy and other treatments from losing their effectiveness in treating cancer over time.
- Growing in low tufty patches.